The collaborative MPhil and PhD programme was the first of its kind in the uk pharmaceutical industry when established in 2009. It provides an innovative framework for personal advancement, enabling GSK employees - registered as research students with Strathclyde - to work towards higher research degrees through their work-based projects.
In 2012, the overall endeavours with GSK were further extended with the establishment of an industrial PhD Programme in Synthetic and Medicinal Chemistry. Cohorts of new top graduates, ie not GSK employees, engage in PhD studies either within GSK or Strathclyde laboratories, with secondments in both directions.
The Strathclyde-GSK research partnership is now recognised within GSK as a landmark programme for the development of early talent and central to GSK strategy and policy within the associated research areas.
Collaborations cover a wide spectrum of research areas, including in the following domains:
- Synthetic & Medicinal Chemistry
- Process Chemistry
- Analytical Chemistry
- Computational Chemistry & Informatics
- Drug Metabolism & Pharmacokinetics
- Biological Sciences
- Biopharmaceuticals
Notably, the programme has encompassed students from both the Research & Development and Global Manufacturing & Supply sectors of GSK.
Across the programme, research projects are carefully selected to advance innovation and understanding in areas of science that are relevant to the pharmaceutical industry in general or GSK in particular.
